Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Diabetic mastopathy


Other Names for this Disease

  • Diabetic fibrous breast disease
  • Diabetic fibrous mastopathy
  • Lymphocytic mastitis
  • Lymphocytic mastopathy
  • Sclerosing lymphocytic lobulitis
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Your Question

How is diabetic mastopathy diagnosed and treated?

Our Answer

We have identified the following information that we hope you find helpful. If you still have questions, please contact us.

What is diabetic mastopathy?

Diabetic mastopathy are noncancerous lesions in the breast most commonly diagnosed in premenopausal women with type 1 diabetes.[1][2][3] The cause of this condition is unknown.[1][2][3][4][5] Symptoms may include hard, irregular, easily movable, discrete, painless breast mass(es).[1][4][6]
Last updated: 7/24/2013

What are the symptoms of diabetic mastopathy?

Common symptoms of diabetic mastopathy include hard, irregular, easily movable, discrete, painless breast mass(es).[1] This condition can involve one or both breasts and can affect males and females.[1] The breast lesions may not be palpable in some patients.[1] Patients with diabetic mastopathy who have had insulin-requiring diabetes for a long time (>15 years) commonly have other diabetes complications as well (e.g., thyroid, eye, and joint involvement).[1][5]
Last updated: 10/15/2009

How is diabetic mastopathy diagnosed?

The diagnosis of diabetic mastopathy should be considered in patients with long-standing insulin-dependent diabetes and a firm, mobile breast mass. Initial imaging may include mammography and ultrasound. While these methods can help to further differentiate the mass, they cannot provide a specific diagnosis of diabetic mastopathy with confident exclusion of malignancy.[7] Magnetic resonance imaging (MRI) is unlikely to add additional information. Current practice dictates that a core biopsy (utilizing a needle to remove a small cylinder of tissue) be performed for a definitive diagnosis.[8][7]  Biopsy results demonstrate lymphocytic lobulitis and ductitis, glandular atrophy (wasting), perivascular inflammation (vasculitis), dense keloid fibrosis (scarring), and epithelioid fibroblasts.[5][7][9]
 
Last updated: 10/15/2009

How is diabetic mastopathy treated?

Diabetic mastopathy is a benign condition and should be managed as such. Patients should be advised about the condition and how to self examine the breasts. They should be advised that iif there are any changes in size and number of breast lumps that they should consult their breast team or general practitioner. Patients should be routinely followed up with MRI or ultrasound and core biopsy if the lesions become clinically or radiologically suspicious. Lesions can be excised for cosmetic reasons or if malignancy cannot be excluded. No followup is recommended when malignancy has been ruled out.[7]
Last updated: 10/15/2009

Does diabetic mastopathy increase a person's risk for developing breast cancer?

No. Diabetic mastopathy does not increase a person's risk for developing breast cancer.[1][2][4] The small number of reported cases (three) which describe malignancy in patients with diabetic mastopathy are believed to be due to coincidence. There is no pathologic literature linking diabetic mastopathy with malignancy.[5]
Last updated: 10/15/2009

References
Other Names for this Disease
  • Diabetic fibrous breast disease
  • Diabetic fibrous mastopathy
  • Lymphocytic mastitis
  • Lymphocytic mastopathy
  • Sclerosing lymphocytic lobulitis
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.